Zinc Ion

Zinc Ion

SCHEMBL29544545

CCCCCCC(CCCC)C(=O)[O-].CCCCCCC(CCCC)C(=O)[O-].[Zn+2]

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 4/20 0.92
▸ NFKB1 P19838 3/20 0.60
▸ CYP3A4 P08684 2/20 0.60
▸ TSHR P16473 2/20 0.60
▸ NPSR1 Q6W5P4 2/20 0.60
▸ CA1 P00915 3/20 0.57
▸ GPR84 Q9NQS5 4/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ GRIK1 P39086 1/20 0.47
▸ GRIK2 Q13002 1/20 0.47
▸ FFAR1 O14842 1/20 0.47
▸ MAPT P10636 1/20 0.45
▸ LCK P06239 1/20 0.45
▸ PPARD Q03181 1/20 0.45
▸ ZDHHC20 Q5W0Z9 1/20 0.45
▸ ZDHHC2 Q9UIJ5 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Zinc Ion SCHEMBL9770350 0.98 CA2 (0.88) CA2NFKB1CYP3A4TSHRNPSR1
Zinc Ion SCHEMBL31347362 0.98 CA2 (0.88) CA2NFKB1CYP3A4TSHRNPSR1
Potassium Ion SCHEMBL31730243 0.96 CA2 (0.92) CA2NFKB1CYP3A4TSHRNPSR1
SCHEMBL688744 0.96 CA2 (1.00) CA2NFKB1CYP3A4TSHRNPSR1
SCHEMBL31462035 0.96 CA2 (0.92) CA2NFKB1CYP3A4TSHRNPSR1
SCHEMBL6283705 0.96 CA2 (0.92) CA2NFKB1CYP3A4TSHRNPSR1
Potassium Ion SCHEMBL18317043 0.96 CA2 (0.92) CA2NFKB1CYP3A4TSHRNPSR1
SCHEMBL6283709 0.96 CA2 (0.92) CA2NFKB1CYP3A4TSHRNPSR1
SCHEMBL4925037 0.96 CA2 (0.92) CA2NFKB1CYP3A4TSHRNPSR1
SCHEMBL11297019 0.96 CA2 (0.92) CA2NFKB1CYP3A4TSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552989-B2 Quantum dot, and ink composition, light-emitting device, optical member, and apparatus including the same SAMSUNG DISPLAY CO., LTD. (KR) 2026-02-17 — — US claimed
WO-2025063579-A1 QUANTUM DOT, AND INK COMPOSITION, LIGHT-EMITTING DEVICE, OPTICAL MEMBER AND APPARATUS COMPRISING SAME 삼성디스플레이주식회사 2025-03-27 — — WO claimed
US-20250092310-A1 QUANTUM DOT, AND INK COMPOSITION, LIGHT-EMITTING DEVICE, OPTICAL MEMBER, AND APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2025-03-20 — — US claimed
US-12552989-B2 Quantum dot, and ink composition, light-emitting device, optical member, and apparatus including the same SAMSUNG DISPLAY CO., LTD. (KR) 2026-02-17 — — US disclosed
WO-2025063579-A1 QUANTUM DOT, AND INK COMPOSITION, LIGHT-EMITTING DEVICE, OPTICAL MEMBER AND APPARATUS COMPRISING SAME 삼성디스플레이주식회사 2025-03-27 — — WO disclosed
US-20250092310-A1 QUANTUM DOT, AND INK COMPOSITION, LIGHT-EMITTING DEVICE, OPTICAL MEMBER, AND APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2025-03-20 — — US disclosed
CN-114044890-B Amphiphilic polycaprolactone polyol and preparation method and application thereof 万华化学集团股份有限公司 2023-12-19 — — CN disclosed
CN-114044890-A Amphiphilic polycaprolactone polyol and preparation method and application thereof 万华化学集团股份有限公司 2022-02-15 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552989-B2 Quantum dot, and ink composition, light-emitting device, optical member, and apparatus including the same RB1, RALA, LASP1 CA2 2021/4885NFKB1 2904/4885CYP3A4 3689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback